EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Senti Biosciences, Inc. (SNTI) had EBIT Margin of -85229.41% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.02M |
|
$-12.75M |
|
-- |
|
$0.02M |
|
$14.51M |
|
$-14.49M |
|
$1.74M |
|
$-12.75M |
|
$-12.75M |
|
$-12.75M |
|
$-12.75M |
|
$-12.75M |
|
$-12.75M |
|
$-14.49M |
|
$-13.82M |
|
31.14M |
|
31.14M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$13.01M |
|
$11.43M |
|
$20.10M |
|
$33.10M |
|
$15.77M |
|
-- |
|
$20.74M |
|
$36.51M |
|
$-3.40M |
|
$-3.40M |
|
$-3.40M |
|
31.14M |
|
| Cash Flow Statement Financials | |
$-21.73M |
|
$0.11M |
|
$9.56M |
|
$19.95M |
|
$7.89M |
|
$-12.06M |
|
$2.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.83 |
|
-- |
|
-- |
|
-- |
|
-1.17 |
|
100.00% |
|
-85229.41% |
|
|
EBIT Margin |
-85229.41% |
-- |
|
-74999.99% |
|
-74999.99% |
|
$-21.62M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.00 |
|
0.03M |
|
374.89% |
|
374.89% |
|
-38.51% |
|
374.89% |
|
$-0.11 |
|
$-0.69 |
|
$-0.70 |
|